Related Experiment Video
Updated: Mar 19, 2026

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
MiR-502-3P suppresses cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting SET
Haosheng Jin1, Min Yu1, Ye Lin1
1Department of General Surgery, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, People's Republic of China.
Background/Aim:
Increasing evidences show that microRNAs are engaged in hepatocellular carcinoma (HCC). The aim of this study was to investigate the role of miR-502-3P in HCC and to identify its underlying mechanism.
Methods:
The expression levels of miR-502-3P were assessed in multiple HCC cell lines and in liver tissues of patients with HCC. We further examined the effects of miR-502-3P on malignant behavior of HCC. The molecular target of miR-502-3P was identified using a computer algorithm and confirmed experimentally.
Results:
Downregulation of miR-502-3P was found in both HCC cell lines and human samples. Overexpression of miR-502-3P dramatically inhibits HCC proliferation, metastasis, invasion, and cell adhesion. We further verify the SET as a novel and direct target of miR-502-3P in HCCs.
Conclusion:
Taken together, overexpression of miR-502-3P or downregulation of SET may prove beneficial as a therapeutic strategy for HCC treatment.
Insights
MicroRNA-502-3p (miR-502-3p) is downregulated in hepatocellular carcinoma (HCC). Restoring miR-502-3p inhibits HCC progression and targets SET, offering a potential therapeutic strategy.
Area of Science:
- Molecular biology
- Oncology
- Biochemistry
Background:
- MicroRNAs (miRNAs) play crucial roles in cancer development.
- Hepatocellular carcinoma (HCC) is a significant global health concern.
- The specific role of miR-502-3p in HCC pathogenesis requires elucidation.
Purpose of the Study:
- To investigate the expression and function of miR-502-3p in HCC.
- To identify the molecular mechanisms underlying miR-502-3p's action in HCC.
- To explore the therapeutic potential of miR-502-3p in HCC treatment.
Main Methods:
- Assessed miR-502-3p expression in HCC cell lines and patient tissues.
- Evaluated the impact of miR-502-3p on HCC cell proliferation, invasion, and metastasis.
- Identified and experimentally validated the direct molecular target of miR-502-3p.
Main Results:
- miR-502-3p was significantly downregulated in HCC.
- Overexpression of miR-502-3p suppressed HCC cell proliferation, invasion, metastasis, and adhesion.
- SET was confirmed as a direct target of miR-502-3p in HCC.
Conclusions:
- miR-502-3p functions as a tumor suppressor in HCC.
- Targeting SET or enhancing miR-502-3p levels may offer a novel therapeutic approach for HCC.
- Further research into miR-502-3p and SET interactions is warranted for clinical applications.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation

